News & updateValanx Biotech Raises €3M in FinancingadminMarch 12, 2026 by adminMarch 12, 2026026 Congrats to our SOSV portfolio company VALANX Biotech on its €3 million in new funding to advance its lead antibody-drug conjugate (ADC) program. The financing...